Alberta’s life sciences sector had a year that shows both what it can produce and where it has room to grow. Start Alberta now tracks 390 life sciences companies in the province, and disclosed funding and acquisition value has reached $374 million across 20 transactions so far in 2026.
Most of that total comes from one deal: Grindr’s pending acquisition of Calgary-based PurposeMed, announced in October. Outside that deal, this year’s activity has come largely from seed rounds, early-stage funding and grants, and no Alberta life sciences company has disclosed a Series A or later round so far in 2026.
That gap between a broad base of early-stage companies and a small number of growth-stage rounds is one of the clearest opportunities in the data for founders, investors and partners working to grow the sector.
Our new 2026 Alberta Life Sciences Technology Landscape report provides a comprehensive look at the companies, funding patterns and talent trends shaping this sector.
What’s in the report
This Deep Dive provides a comprehensive analysis of Alberta’s life sciences landscape, examining 390 companies across biotechnology, pharmaceuticals, medical devices and digital health.
The report covers:
- Funding and acquisition activity since 2018, including the largest transactions of 2026
- Enterprise value growth across biotechnology, health platforms and medical devices
- Bootstrapped companies and the capital needs of the sector
- Talent trends and company size across the sector
- Where Alberta ranks among Canada’s life sciences hubs
- The mix of Canadian and international investors behind the country’s life sciences deals
Discover where capital is flowing, which companies are operating at scale and how Alberta’s life sciences sector compares nationally.
Methodology
For this report, “life sciences” includes biotechnology, pharmaceuticals, medical devices and digital health companies, excluding in-person clinics and care providers. Our analysis draws on Dealroom data, and transaction totals include equity, debt and acquisitions. The report’s Methodology section has full details.